AFRM vs CRVO · P/E 590, rev $4.26B vs $28.8M cap
Affirm Holdings Inc (AFRM) versus CervoMed Inc. (CRVO) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2026-06-30 was $4.26B. Net income was $1.93B. Revenue was up 32.2% from 2025-06-30 to 2026-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. CRVO currently screens at market cap $28.8M.
Not investment advice. Open the AFRM and CRVO stock pages for the full models.
Not investment advice.